These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
819 related articles for article (PubMed ID: 28772160)
1. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Abdelgawad MA; Bakr RB; Omar HA Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240 [TBL] [Abstract][Full Text] [Related]
3. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. Abdelgawad MA; Bakr RB; Ahmad W; Al-Sanea MM; Elshemy HAH Bioorg Chem; 2019 Nov; 92():103218. PubMed ID: 31536956 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives. Ren B; Liu RC; Ji K; Tang JJ; Gao JM Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A Bioorg Med Chem Lett; 2003 Feb; 13(4):657-60. PubMed ID: 12639552 [TBL] [Abstract][Full Text] [Related]
6. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation. Xiang P; Zhou T; Wang L; Sun CY; Hu J; Zhao YL; Yang L Molecules; 2012 Jan; 17(1):873-83. PubMed ID: 22252503 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimicrobial and cytotoxic activities of pyrimidinyl benzoxazole, benzothiazole and benzimidazole. Seenaiah D; Reddy PR; Reddy GM; Padmaja A; Padmavathi V; Krishna NS Eur J Med Chem; 2014 Apr; 77():1-7. PubMed ID: 24607584 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase. Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma. Dadashpour S; Küçükkılınç TT; Ercan A; Hosseinimehr SJ; Naderi N; Irannejad H Anticancer Agents Med Chem; 2019; 19(17):2120-2129. PubMed ID: 31393257 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro antiproliferative evaluation of some B-norcholesteryl Benzimidazole and Benzothiazole derivatives. Cui J; Qi B; Gan C; Liu Z; Huang H; Lin Q; Zhao D; Huang Y Mar Drugs; 2015 Apr; 13(4):2488-504. PubMed ID: 25913705 [TBL] [Abstract][Full Text] [Related]
14. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties. Cindrić M; Jambon S; Harej A; Depauw S; David-Cordonnier MH; Kraljević Pavelić S; Karminski-Zamola G; Hranjec M Eur J Med Chem; 2017 Aug; 136():468-479. PubMed ID: 28525845 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities. A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546 [TBL] [Abstract][Full Text] [Related]
19. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling. Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522 [TBL] [Abstract][Full Text] [Related]
20. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition. Ren SZ; Wang ZC; Zhu XH; Zhu D; Li Z; Shen FQ; Duan YT; Cao H; Zhao J; Zhu HL Bioorg Med Chem; 2018 Aug; 26(14):4264-4275. PubMed ID: 30031652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]